- Projects & figures
- News & Events
- Managing your project
- About ERC
Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.
Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With his studies, he hoped to bring new insight into pregnancy-associated malaria, to save the lives of women and their babies in areas affected by the disease. Now, Dr Salanti’s research has shifted to battling against another deadly disease: cancer. This comes after an unexpected discovery yielded ground-breaking results for the diagnosis and treatment of this illness. This is the kind of curiosity-driven research that can lead to ground-breaking serendipitous outcomes.
During the 20th century, the experiences of post-communist states in Central and Eastern Europe were very different from those of much of Western Europe. Have these different experiences fostered different attitudes when it comes to public space, and ‘public goods’ like health care, education or the environment? Dr Natalia Letki of the University of Warsaw in Poland is using an ERC Starting Grant to carry out an ambitious multi-disciplinary study of attitudes and behaviour regarding ‘public goods’ across this region – drawing on political science, sociology, economics and even psychology.